human | Q5 |
P8168 | FactGrid item ID | Q885393 |
P227 | GND ID | 112832776 |
P10299 | Leopoldina member ID (new) | matthias-w-beckmann |
P214 | VIAF ID | 673623 |
P7859 | WorldCat Identities ID (superseded) | lccn-n2015016908 |
P166 | award received | Cross of the Order of Merit of the Federal Republic of Germany | Q10905380 |
P27 | country of citizenship | Germany | Q183 |
P734 | family name | Beckmann | Q813731 |
Beckmann | Q813731 | ||
Beckmann | Q813731 | ||
P735 | given name | Matthias | Q4927273 |
Matthias | Q4927273 | ||
P1412 | languages spoken, written or signed | German | Q188 |
P463 | member of | German Academy of Sciences Leopoldina | Q543804 |
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
Q30317570 | 13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013). |
Q30315970 | 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts |
Q34209167 | 18-Year-Old Woman with an Embryonal Rhabdomyosarcoma of the Uterus in Statu Nascendi |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
Q26768670 | A Review of Integrative Medicine in Gynaecological Oncology |
Q40486932 | A Standard Mammography Unit - Standard 3D Ultrasound Probe Fusion Prototype: First Results |
Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
Q35957063 | A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density |
Q33747778 | A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. |
Q29417084 | A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. |
Q53650107 | A hybrid method towards automated nipple detection in 3D breast ultrasound images. |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q35089479 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population |
Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
Q24626194 | A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer |
Q37575167 | A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study |
Q33947899 | ABCA transporter gene expression and poor outcome in epithelial ovarian cancer |
Q37227494 | ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas |
Q62583469 | Abstract 5488: Utilizing a pathway based analysis of genome wide association data to identify biomarkers of toxicity in breast cancer patients |
Q46169815 | Abstract 73: Selective Isolation And Characterization Of Different Cell Types From Mammary Gland And Carcinoma Tissue For Subsequent Analysis Of Cell-cell Interactions. |
Q38371558 | Accelerated Partial Breast Irradiation With Interstitial Implants: Risk Factors Associated With Increased Local Recurrence |
Q40497331 | Accelerated partial breast irradiation with external beam radiotherapy : First results of the German phase 2 trial |
Q47347187 | Accuracy of radiological tumour size assessment and the risk for re-excision in a cohort of primary breast cancer patients |
Q58695244 | Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria |
Q38406780 | Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study |
Q52647897 | Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. |
Q39432829 | Akt and p53 are potential mediators of reduced mammary tumor growth by cloroquine and the mTOR inhibitor RAD001. |
Q34371653 | An EMR based cancer diary - utilisation and initial usability evaluation of a new cancer data visualization tool |
Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
Q61853700 | An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer |
Q42371458 | Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci |
Q35874160 | Analysis and classification of oncology activities on the way to workflow based single source documentation in clinical information systems |
Q64101095 | Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support Causality |
Q36831854 | Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome |
Q38667762 | Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A study |
Q47102240 | Antioxidant effect of aqueous extract of four plants with therapeutic potential on gynecological diseases; Semen persicae, Leonurus cardiaca, Hedyotis diffusa, and Curcuma zedoaria |
Q50799567 | Apolipoprotein E synthesis by cultured human ovarian granulosa cells: regulation by human chorionic gonadotropin and cholesterol |
Q62583468 | Arbeitsgruppe Integrative Medizin (AG IMed) der AGO e.V.. Begriffsdefinition, Gründung, Ziele und Perspektiven der AG Integrative Medizin |
Q34138371 | Are Certified Breast Centers Cost-Effective? |
Q35142156 | Aspects of molecular diagnostics and therapy in obstetrics and gynecology |
Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
Q30276986 | Assessing the genetic architecture of epithelial ovarian cancer histological subtypes |
Q50958797 | Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation. |
Q37383194 | Assessment of University Gynaecology Clinics Based on Quality Reports |
Q46687084 | Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself*. |
Q47399153 | Assessment of breast cancer tumour size using six different methods |
Q46186737 | Assessment of pituitary and steroid hormones and members of the TGF-beta superfamily for ovarian function in patients with congenital uterus and vaginal aplasia (MRKH syndrome). |
Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
Q37684409 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q35006860 | Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen |
Q33828680 | Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival |
Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
Q53650262 | Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study. |
Q44287591 | Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer |
Q41706112 | Association of molecular subtypes with breast cancer risk factors: a case-only analysis |
Q43271915 | Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS. |
Q39423088 | Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study |
Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
Q33812789 | Attention, cognitive control and motivation in ADHD: Linking event-related brain potentials and DNA methylation patterns in boys at early school age. |
Q46143272 | Automatic texture-based analysis in ultrasound imaging of ovarian masses |
Q57990746 | BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients |
Q36295142 | Biomarkers in Breast Cancer - An Update |
Q43945969 | Blood group A: an overseen risk factor for early-onset ovarian hyperstimulation syndrome? |
Q51553410 | Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. |
Q42165395 | Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome |
Q70536430 | Breaks in DNA accompany estrogen-receptor-mediated cytotoxicity from 16 alpha[125I]iodo-17 beta-estradiol |
Q37660589 | Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis |
Q34201805 | Breast Cancer Risk - Genes, Environment and Clinics |
Q43122429 | Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial |
Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
Q44973328 | Breast cancer: assessment of individual risk and possibilities for prevention |
Q39978884 | Breast volumetry using a three-dimensional surface assessment technique |
Q52849107 | CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients. |
Q53407302 | CD95 ligand expression as a criterion of malignant transformation in breast cancer. |
Q73395786 | CD95 ligand expression as a mechanism of immune escape in breast cancer |
Q56975238 | CD95 ligand expression in dedifferentiated breast cancer |
Q36620625 | CDKN2A gene inactivation in epithelial sporadic ovarian cancer |
Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
Q36419325 | CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer |
Q34793437 | CYP2B6*6 is associated with increased breast cancer risk |
Q37524058 | CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations |
Q61446902 | Can a University Reproductive Medicine Centre Be Financed Under the Pre-Existing General Conditions in Germany? |
Q28385765 | Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk |
Q43639604 | Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group |
Q33481987 | Certification of breast centres in Germany: proof of concept for a prototypical example of quality assurance in multidisciplinary cancer care |
Q36286192 | Cervical Cancer Screening: Defining the Need for Research |
Q53172588 | Changes in satisfaction in patients with gynaecological and breast malignancies: an analysis with the Socio-Economic Satisfaction and Quality of Life questionnaire. |
Q36245595 | Characterizing mammographic images by using generic texture features |
Q51532003 | Chelidonium majus and its effects on uterine contractility in a perfusion model. |
Q57098750 | Children of Prenatally Depressed Mothers: Externalizing and Internalizing Symptoms are Accompanied by Reductions in Specific Social-Emotional Competencies |
Q73020768 | Chronic pelvic pain syndrome (CPPS) and chronic vulvar pain syndrome (CVPS): evaluation of psychosomatic aspects |
Q47657648 | Chylous ascites after lymphadenectomy for gynecological malignancies |
Q34221705 | Circulating miR-148b and miR-133a as biomarkers for breast cancer detection |
Q21134914 | Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection |
Q33958981 | Circulating tumor cells predict survival in early average-to-high risk breast cancer patients |
Q35782435 | Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer |
Q33991395 | Clinical aspects of Mayer-Rokitansky-Kuester-Hauser syndrome: recommendations for clinical diagnosis and staging |
Q36798908 | Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer |
Q45746480 | Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity |
Q35668946 | Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk |
Q34126314 | Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer |
Q35891162 | Common breast cancer susceptibility loci are associated with triple-negative breast cancer |
Q36600605 | Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk |
Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
Q29417145 | Common variants at 19p13 are associated with susceptibility to ovarian cancer |
Q36255665 | Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q37681445 | Comparison of Obstetric Efficacy and Safety of the Kiwi OmniCup with Conventional Vacuum Extraction |
Q35054469 | Comparison of Sonography versus Digital Breast Tomosynthesis to Locate Intramammary Marker Clips |
Q53318719 | Comparison of Whole Ovary Cryotreatments for Fertility Preservation. |
Q51035304 | Comparison of different diagnostic procedures for the staging of malformations associated with Mayer-Rokitansky-Küster-Hauser syndrome. |
Q51281139 | Comparison of prevalence of hypoactive sexual desire disorder (HSDD) in women after five different hysterectomy procedures. |
Q34428536 | Comparison of reoperation rates, perioperative outcomes in women with endometrial cancer when the standard of care shifts from open surgery to laparoscopy |
Q62583610 | Comparison of total laparoscopic hysterectomy (TLH) and laparoscopy-assisted supracervical hysterectomy (LASH) in women with uterine leiomyoma |
Q50648173 | Comparison of two freezing protocols in an open freezing system for cryopreservation of rat ovarian tissue. |
Q72167239 | Comparisons of radioiodoestradiol blood-tissue exchange after intravenous or intraarterial injection |
Q62583467 | Competitive analysis of pregnancy associated HLA-proteins in trophoblast and breast cancer tissue |
Q36026731 | Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer |
Q39256294 | Comprehensive visualization of paresthesia in breast cancer survivors |
Q40069574 | Computer-assisted diagnosis in colposcopy: results of a preliminary experiment? |
Q31107007 | Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients |
Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
Q26748714 | Considerations on the Improved Integration of Medical Guidelines into Routine Clinical Practice – a Review and Concept Proposal |
Q34342248 | Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q46494349 | Correlates of the desire for improved cosmetic results after breast-conserving therapy and mastectomy in breast cancer patients |
Q37855560 | Correlation of high-risk human papilloma viruses but not of herpes viruses or Chlamydia trachomatis with endometriosis lesions |
Q37452184 | Correlation of histological and macroscopic findings in peritoneal endometriosis |
Q34714884 | Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes. |
Q34278775 | Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer, Based on Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care System |
Q43100791 | Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system |
Q47435062 | Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer |
Q34210292 | Cryopreservation of Ovarian Tissue: Detailed Description of Methods for Transport, Freezing and Thawing |
Q37681448 | Culture of Individually Required Number of 2-Pronuclei-Stage Oocytes - Patient Participation in Decision-Making is in Accordance with the Aim of Avoiding Surplus Embryo Freezing |
Q33626108 | DGGG Guidelines Programme: Status Quo - Quo Vadis! |
Q36540420 | DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer |
Q33209076 | DNA sequence variations of the entire anti-Mullerian hormone (AMH) gene promoter and AMH protein expression in patients with the Mayer-Rokitanski-Kuster-Hauser syndrome |
Q34042835 | Defining CD95 as a tumor suppressor gene |
Q48635565 | Delivery mode and the course of pre- and postpartum depression. |
Q53400920 | Desire to Have Children Among Transgender People in Germany: A Cross-Sectional Multi-Center Study. |
Q36069885 | Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial |
Q73133671 | Detection of sequential genetic alterations relevant for breast cancer development |
Q67516764 | Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assays |
Q50186421 | Detyrosinated tubulin is decreased in fetal vessels of preeclampsia placentas. |
Q35624654 | Development and Validation of a Standardized Questionnaire and Standardized Diary for Use in Integrative Medicine Consultations in Gynecologic Oncology |
Q42483480 | Dexamethasone stimulates the expression of leptin and 11β-HSD2 in primary human placental trophoblastic cells |
Q47952423 | Did you drink alcohol during pregnancy? Inaccuracy and discontinuity of women's self-reports: On the way to establish meconium ethyl glucuronide (EtG) as a biomarker for alcohol consumption during pregnancy |
Q56679615 | Die Extrauteringravidität |
Q54447695 | Differences in gene expression dependent on sampling site in placental tissue of fetuses with intrauterine growth restriction. |
Q46310619 | Differences in muscarinic-receptor agonist-, oxytocin-, and prostaglandin-induced uterine contractions |
Q50898218 | Differential effects of low birthweight and intrauterine growth restriction on umbilical cord blood insulin-like growth factor concentrations. |
Q50868171 | Digit ratio (2D:4D) and behavioral symptoms in primary-school aged boys. |
Q41506407 | Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation |
Q48607117 | Does stimulation with human gonadotropins and gonadotropin-releasing hormone agonist enhance and accelerate the developmental capacity of oocytes in human ovarian tissue xenografted into severe combined immunodeficient mice? |
Q47182019 | Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety |
Q51200174 | Double-balloon catheter and sequential oral misoprostol versus oral misoprostol alone for induction of labour at term: a retrospective cohort study. |
Q40465468 | Double-balloon catheter and sequential vaginal prostaglandin E2 versus vaginal prostaglandin E2 alone for induction of labor after previous cesarean section. |
Q48672490 | Ductal carcinoma in situ -- do we really need a new nomenclature? |
Q39445654 | Dynamic contrast-enhanced micro-CT on mice with mammary carcinoma for the assessment of antiangiogenic therapy response |
Q36685211 | ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin‐embedded breast carcinoma tissues |
Q39936321 | Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen |
Q41375213 | Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines |
Q38203252 | Economic constraints - the growing challenge for Western breast cancer centers |
Q47104970 | Effect of Premature Rupture of Membranes on Induction of Labor: A Historical Cohort Study |
Q46726174 | Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. |
Q51512980 | Effects of interactions between progesterone and prostaglandin on uterine contractility in a perfused swine uterus model. |
Q43003217 | Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals |
Q47273243 | Effects of prenatal alcohol consumption on cognitive development and ADHD-related behaviour in primary-school age: a multilevel study based on meconium ethyl glucuronide |
Q40273075 | Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machinery. |
Q45982068 | Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. |
Q58748170 | Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial |
Q34397557 | Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5). |
Q41097198 | Efficient lysis of CD44v7/8-presenting target cells by genetically engineered cytotoxic T-lymphocytes--a model for immunogene therapy of cervical cancer |
Q22250928 | Einfluss des mütterlichen Alkoholkonsums während der Schwangerschaft auf die Entwicklung von ADHS beim Kind |
Q52681182 | Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study. |
Q35794508 | Endogenous retroviral syncytin: compilation of experimental research on syncytin and its possible role in normal and disturbed human placentogenesis |
Q35815412 | Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study |
Q37867025 | Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL. |
Q24633316 | Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer |
Q36487146 | Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk |
Q57961643 | Erratum to “Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients—Design and baseline data ‘LIBERATE’ trial” [The Breast 16S2 (2007) S182–S189] |
Q42649791 | Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer |
Q57319395 | Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer |
Q43179803 | Erratum: Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015). |
Q34243929 | Establishment of the Certification System "Gynaecological Dysplasia" in Germany |
Q28239860 | Estrogen and progesterone receptors: from molecular structures to clinical targets |
Q33932856 | Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium |
Q36617728 | European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium |
Q36966218 | Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study |
Q37389684 | Evaluation of Newly Adapted Clip Marker System in Ultrasound-Guided Core Needle Biopsy for Suspicion of Breast Cancer |
Q34764981 | Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study |
Q51809365 | Evaluation of high-sensitivity C-reactive protein in comparison with C-reactive protein as biochemical serum markers in women with endometriosis. |
Q43697261 | Evaluation of mathematical models for breast cancer risk assessment in routine clinical use. |
Q37719099 | Evaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancer |
Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
Q34687073 | Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study |
Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
Q42237987 | Ex vivo expansion of hematopoietic stem- and progenitor cells from cord blood in coculture with mesenchymal stroma cells from amnion, chorion, Wharton's jelly, amniotic fluid, cord blood, and bone marrow |
Q71874733 | Expression analyses of epidermal growth factor receptor and HER-2/neu: no advantage of prediction of recurrence or survival in breast cancer patients |
Q37631322 | Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma |
Q54455169 | Expression of the human endogenous retroviruse-W envelope gene syncytin in endometriosis lesions. |
Q51409088 | Extracorporeal perfusion of the swine uterus: effect of human seminal plasma. |
Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
Q30313653 | Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study |
Q45006117 | Factors influencing breast changes after pregnancy |
Q64935138 | Fat necrosis after conserving surgery and interstitial brachytherapy and/or external-beam irradiation in women with breast cancer. |
Q40365623 | Feasibility and safety of total laparoscopic hysterectomy (TLH) using the Hohl instrument in nonobese and obese women |
Q31150676 | FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients |
Q51775578 | Female genital malformations and their associated abnormalities. |
Q36539587 | Femoral Placement of Totally Implantable Venous Access Ports in Patients with Bilateral Breast Cancer |
Q26771340 | Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled? |
Q49340655 | Fertility protection: complications of surgery and results of removal and transplantation of ovarian tissue. |
Q36841308 | Fetal Rhesus D genotyping on amniocytes in alloimmunised pregnancies using fluorescence duplex polymerase chain reaction |
Q46500853 | Fetal weight estimation in extreme macrosomia (≥ 4,500 g): comparison of 10 formulas |
Q49796329 | Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients. |
Q50748345 | Financial viability of perinatal centers in the longer term, taking legislative requirements into account. An examination of the cost-revenue structure of a Level I perinatal center. |
Q44318881 | Financing of certified centers: a willingness-to-pay analysis |
Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q35063160 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk |
Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q37002930 | Five endometrial cancer risk loci identified through genome-wide association analysis |
Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
Q71722021 | Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer |
Q36295117 | Full Field Digital Mammography (FFDM) versus CMOS Technology versus Tomosynthesis (DBT) - Which System Increases the Quality of Intraoperative Imaging? |
Q37395450 | Full Field Digital Mammography (FFDM) versus CMOS Technology, Specimen Radiography System (SRS) and Tomosynthesis (DBT) - Which System Can Optimise Surgical Therapy? |
Q51771739 | Fulvestrant: a further treatment option for patients with metastatic uterine cancer? |
Q50053485 | Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening. |
Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q36956156 | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer |
Q55037331 | Galactography with Tomosynthesis Technique (Galactomosynthesis) - Renaissance of a Method? |
Q73886723 | Gene amplification and expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas |
Q35793260 | Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation |
Q48361014 | Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2. |
Q40137431 | Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium |
Q41040904 | Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study |
Q37389405 | Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer |
Q115209620 | Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus |
Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
Q54940815 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. |
Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
Q45968079 | Genetic risk factors for ovarian cancer and their role for endometriosis risk. |
Q46721561 | Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study |
Q37679549 | Genetic variants in the genes of the stress hormone signalling pathway and depressive symptoms during and after pregnancy |
Q48657862 | Genetic variants in the tryptophan hydroxylase 2 gene (TPH2) and depression during and after pregnancy. |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
Q36218993 | Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
Q29417135 | Genome-wide association study identifies a common variant associated with risk of endometrial cancer |
Q36024614 | Genome-wide association study identifies a possible susceptibility locus for endometrial cancer |
Q33778612 | Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. |
Q59566871 | Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility |
Q38823212 | Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk |
Q36916243 | Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer |
Q30315508 | Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032/049, December 2015). |
Q36539030 | Gonadal damage and options for fertility preservation in female and male cancer survivors |
Q40090312 | Grating-based darkfield imaging of human breast tissue |
Q41501180 | Growth inhibition of xenotransplanted human carcinomas by a monoclonal antibody directed against the epidermal growth factor receptor |
Q38672994 | Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey |
Q28237833 | HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer |
Q46188099 | HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics |
Q38002315 | HIV-associated hypertrophic herpes simplex genitalis with concomitant early invasive squamous cell carcinoma mimicking advanced genital cancer: case report and literature review |
Q46475402 | HOXA10 and HOXA13 sequence variations in human female genital malformations including congenital absence of the uterus and vagina |
Q42191135 | HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions. |
Q26996601 | Health Services Research and Health Economy - Quality Care Training in Gynaecology, with Focus On Gynaecological Oncology |
Q37677719 | Health economics in breast cancer |
Q48086218 | Health utilities in gynecological oncology and mastology in Germany |
Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
Q36311502 | Hereditary breast and ovarian cancer: review and future perspectives |
Q46580962 | High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone |
Q35878239 | High incidence of recurrent copy number variants in patients with isolated and syndromic Müllerian aplasia |
Q54566127 | Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial. |
Q34010295 | Higher incidence of linked malformations in siblings of Mayer-Rokitansky-Küster-Hauser-syndrome patients |
Q40060927 | History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium |
Q46310632 | Hormonal and histologic findings in human cryopreserved ovarian autografts |
Q35815464 | Hormone Therapy and its Effect on the Prognosis in Breast Cancer Patients |
Q73843914 | Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence rates |
Q43694432 | Hormone replacement therapy and prognosis in ovarian cancer patients |
Q34360924 | Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer |
Q68037064 | Human ovarian granulosa cell culture: determination of blood cell contamination and evaluation of possible culture purification steps |
Q47844735 | Hyperandrogenemia and high prolactin in congenital utero-vaginal aplasia patients |
Q47110757 | Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma |
Q33606770 | Hypohidrotic Ectodermal Dysplasia: Breastfeeding Complications Due to Impaired Breast Development |
Q24595917 | Hysterectomy-a comparison of approaches |
Q62583606 | Hysterektomie - was ist zeitgemäß? |
Q38479085 | INT-2 gene amplification in differentiated human thyroid cancer. |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q37006170 | Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. |
Q30252854 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer |
Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
Q36014067 | Identification of novel genetic markers of breast cancer survival |
Q35541663 | Identification of six new susceptibility loci for invasive epithelial ovarian cancer |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q71865988 | Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance |
Q37382860 | Impact of Patient and Procedure Mix on Finances of Perinatal Centres - Theoretical Models for Economic Strategies in Perinatal Centres |
Q50866974 | Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry. |
Q38606464 | Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry |
Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
Q47212830 | Increased accuracy of fetal weight estimation with a gender-specific weight formula |
Q64119524 | Induction of Labour in Growth Restricted and Small for Gestational Age Foetuses - A Historical Cohort Study |
Q35428047 | Induction of Labour: Change of Method and its Effects |
Q34764971 | Influence of Patient and Hospital Characteristics on the Performance of Direct Reconstruction after Mastectomy |
Q48280760 | Influence of body mass index on induction of labor: A historical cohort study |
Q47318223 | Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics |
Q50089754 | Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients. |
Q52572827 | Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study. |
Q34996647 | Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer |
Q37684424 | Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q36015063 | Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses |
Q35133135 | Inhibition of adhesion, proliferation, and invasion of primary endometriosis and endometrial stromal and ovarian carcinoma cells by a nonhyaluronan adhesion barrier gel. |
Q37382839 | Innovations in Cervical and Endometrial Cancer |
Q35687548 | Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer |
Q58592781 | Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors o |
Q58124814 | Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Brea |
Q39390636 | Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study |
Q64991267 | Intra- and Postoperative Blood Flow Monitoring in a Sheep Model of Uterus Transplantation. |
Q35695189 | Intracellular actions of steroid hormones and their therapeutic value, including the potential of radiohalosteroids against ovarian cancer |
Q38674400 | Intrauterine Growth Restriction (IUGR) Induces Signs of Subclinical Atherosclerosis in 6-Year-Old Infants Despite Absence Of Excessive Growth |
Q52582782 | Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix. |
Q33990120 | Introduction of Inhaled Nitrous Oxide and Oxygen for Pain Management during Labour - Evaluation of Patients' and Midwives' Satisfaction |
Q35576242 | Invasive Breast Cancer: Recognition of Molecular Subtypes |
Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
Q57644499 | Is laparoscopic extirpation of the cervical stump after laparoscopic supracervical hysterectomy justified in women with incidentally found atypical endometrial hyperplasia? |
Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
Q44303312 | Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients |
Q34074094 | Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment |
Q35745601 | Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases |
Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
Q37725393 | Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome |
Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
Q50984661 | Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. |
Q26800265 | Local and Systemic Therapies for Breast Cancer Patients: Reducing Short-term Symptoms with the Methods of Integrative Medicine |
Q35686043 | Long-Term Endurance Exercise in Humans Stimulates Cell Fusion of Myoblasts along with Fusogenic Endogenous Retroviral Genes In Vivo |
Q51749719 | Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals. |
Q46671490 | Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report |
Q44827804 | Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial |
Q38469677 | Loss of heterozygosity of BRCA1, TP53 and TCRD markers analysed in sporadic endometrial cancer |
Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
Q46983578 | Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome |
Q38126358 | Low-dose methotrexate treatment in ectopic pregnancy: a retrospective analysis of 164 ectopic pregnancies treated between 2000 and 2008. |
Q51057785 | Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit. |
Q38857155 | Major and minor complications after anterior rectal resection for deeply infiltrating endometriosis |
Q45381957 | Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw. |
Q36373761 | Malformations in a cohort of 284 women with Mayer-Rokitansky-Küster-Hauser syndrome (MRKH). |
Q37382835 | Mammographic Density and Prediction of Nodal Status in Breast Cancer Patients |
Q39622978 | Mammographic density is the main correlate of tumors detected on ultrasound but not on mammography |
Q38528926 | Measuring bone density with ultrasound osteodensitometry--results of a pilot study |
Q57561116 | Mechanisms of steroid hormone action and resistance in endometrial and breast cancer |
Q37700515 | Meconium indicators of maternal alcohol abuse during pregnancy and association with patient characteristics |
Q36333368 | Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. |
Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
Q38076833 | Mild hydronephrosis after uncomplicated hysterectomy |
Q61446881 | Mindfulness-based Stress Reduction in Pregnancy: an App-Based Programme to Improve the Health of Mothers and Children (MINDFUL/PMI Study) |
Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
Q51585801 | Modulation of uterine contractility and peristalsis by oxytocin in estrogen-primed non-pregnant swine uteri. |
Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
Q41540149 | Multistep carcinogenesis of breast cancer and tumour heterogeneity |
Q39426753 | Mutation status of the mediator complex subunit 12 (MED12) in uterine leiomyomas and concurrent/metachronous multifocal peritoneal smooth muscle nodules (leiomyomatosis peritonealis disseminata). |
Q39728677 | Myometrial response to neurotropic and musculotropic spasmolytic drugs in an extracorporeal perfusion model of swine uteri |
Q46634705 | Neoadjuvant chemotherapy in breast cancer: which diagnostic procedures can be used? |
Q46419524 | Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial |
Q26799669 | Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk |
Q36631808 | New Screening Proposals: the Federal Joint Commission Defines the Parameters for Cervical Cancer Screening from 2018: Statement of the Gynecology Oncology Working Group (AGO) |
Q42062896 | New WHO Classification of Endometrial Hyperplasias |
Q53254794 | New diagnostic criteria in real-time elastography for the assessment of breast lesions. |
Q38845245 | Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates |
Q30275832 | No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival |
Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
Q26771342 | Non-embryo-destructive Extraction of Pluripotent Embryonic Stem Cells: Implications for Regenerative Medicine and Reproductive Medicine |
Q35752042 | Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures |
Q36027025 | Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium |
Q36689214 | Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval |
Q59616772 | Onkologie. Mammakarzinom: Bisphosphonate in der Adjuvanz – auch aus gesundheitsökonomischer Sicht eine sinnvolle Therapie |
Q39205783 | Optimizing the quality of breast cancer care at certified german breast centers: a benchmarking analysis for 2003-2009 with a particular focus on the interdisciplinary specialty of radiation oncology |
Q38927258 | Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor |
Q47901041 | Ovarian tissue cryopreservation and retransplantation--what do patients think about it? |
Q31108673 | Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis |
Q39827385 | Oxytocin receptor DNA methylation in postpartum depression |
Q47756678 | P(185/Her2) and ps2 protein overexpression in breast-cancer specimens - improvement for prediction of response to endocrine therapy. |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
Q36184231 | PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. |
Q52897474 | PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin |
Q33488582 | Pain perception and detailed visual pain mapping in breast cancer survivors |
Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
Q37382870 | Participation in the SUCCESS-A Trial Improves Intensity and Quality of Care for Patients with Primary Breast Cancer |
Q112572520 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes |
Q52723445 | Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer Patients. |
Q37307937 | Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium |
Q51121776 | Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies. |
Q51029465 | Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant. |
Q73157863 | Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis |
Q34209634 | Percent Mammographic Density and Dense Area as Risk Factors for Breast Cancer |
Q34209656 | Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se |
Q45200398 | Placental defence is considered sufficient to control lipid peroxidation in pregnancy |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q42985583 | Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy |
Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
Q46158039 | Polymorphisms in estrogen metabolism and estrogen pathway genes and the risk of miscarriage |
Q36915870 | Polymorphisms in inflammation pathway genes and endometrial cancer risk |
Q42013702 | Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients |
Q34767999 | Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy |
Q41605982 | Porcine uterus cryopreservation: an analysis of contractile function using different uterotonics |
Q36240019 | Precancerous Lesions of the Cervix, Vulva and Vagina According to the 2014 WHO Classification of Tumors of the Female Genital Tract |
Q41011976 | Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods |
Q42481495 | Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q58101133 | Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer |
Q44634509 | Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers |
Q41714412 | Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center |
Q36010581 | Pregnancy and Obstetrical Outcomes in Women Over 40 Years of Age |
Q34476150 | Pregnancy outcome after maternal intoxication with phenprocoumon |
Q35269825 | Preliminary observations on whole-ovary xenotransplantation as an experimental model for fertility preservation |
Q47755445 | Prenatal and adult androgen activities in alcohol dependence |
Q57476250 | Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis |
Q46635778 | Pretreatment with gonadotropin-releasing hormone (GnRH) antagonists to prevent the flare-up effect of long-acting GnRH agonists: results of a pilot study |
Q34621091 | Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment. |
Q46796735 | Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals |
Q34011730 | Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer |
Q30316383 | Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015). |
Q42512310 | Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients |
Q45756790 | Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis |
Q45408422 | Prognostic significance of serum antibodies to HPV-16 L1 virus-like particles in patients with invasive cervical cancer |
Q45393694 | Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions |
Q54574341 | Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-beta. |
Q67779118 | Prolonged clearance of intraperitoneal 16α-[125I]iodo-17β-estradiol in presence of ascites |
Q42488203 | Proteases associated with gynecological tumors. |
Q73427342 | Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium |
Q51090232 | Psychosomatic aspects of urinary incontinence. |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q43927056 | Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients |
Q43166541 | Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study |
Q36009422 | RAD51B in Familial Breast Cancer |
Q68040369 | Rapid liver metabolism, urinary and biliary excretion, and enterohepatic circulation of 16 alpha-radioiodo-17 beta-estradiol |
Q68073872 | Rat ovarian apolipoprotein E: localization and gonadotropic control of messenger RNA |
Q48173831 | Re-irradiation of the chest wall for local breast cancer recurrence : Results of salvage brachytherapy with hyperthermia |
Q30418097 | Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets |
Q44093156 | Recurrent aberrations identified by array-CGH in patients with Mayer-Rokitansky-Küster-Hauser syndrome |
Q34606561 | Reduced syncytin-1 expression levels in placental syndromes correlates with epigenetic hypermethylation of the ERVW-1 promoter region |
Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
Q40974954 | Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin |
Q39133966 | Regulation of murine placentogenesis by the retroviral genes Syncytin-A, Syncytin-B and Peg10. |
Q39351091 | Regulation of the human endogenous retroviral Syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPARγ/RXRα in placentogenesis |
Q26830250 | Relevance of health economics in breast cancer treatment - the view of certified breast centres and their patients |
Q47119993 | Repetitive Maturation of Oocytes From Non-Stimulated Xenografted Ovarian Tissue From a Prepubertal Patient Indicating the Independence of Human Ovarian Tissue |
Q36799061 | Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone Levels |
Q62583612 | Reply of the Authors: Comparing high-sensitivity C-reactive protein (hs-CRP) with CRP as a soluble serum marker for the diagnosis of women with endometriosis |
Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
Q73721789 | Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene |
Q42970092 | Results of the Zometa cost-utility model for the german healthcare system based on the results of the ABCSG-12 study |
Q35694239 | Retransplantation of cryopreserved ovarian tissue: the first live birth in Germany |
Q37444964 | Review. Fertility preservation for young female cancer patients. |
Q34201814 | Risk Factors for Endometriosis in a German Case-Control Study |
Q36771007 | Risk and risk assessment for breast cancer: molecular and clinical aspects |
Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
Q37624504 | Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10 |
Q54950358 | Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data. |
Q43902013 | Role of estrogen receptor isoforms in the pathogenesis and treatment of endometrial cancer |
Q46681913 | Role of insulin in the progression of ovarian sex cord stromal tumors in rats |
Q53584046 | SPECT/Spiral-CT hybrid imaging in unclear foci of increased bone metabolism: a case report. |
Q46148436 | Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial |
Q55013059 | Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics. |
Q36295510 | Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015). |
Q35121889 | Selective expression of sense and antisense transcripts of the sushi-ichi-related retrotransposon--derived family during mouse placentogenesis |
Q36678970 | Selective isolation and characterization of primary cells from normal breast and tumors reveal plasticity of adipose derived stem cells |
Q64328965 | Self-reported Improvement in Side Effects and Quality of Life With Integrative Medicine in Breast Cancer Patients |
Q39102961 | Semi-automated delineation of breast cancer tumors and subsequent materialization using three-dimensional printing (rapid prototyping). |
Q37382822 | Shaping the System - The DRG Evaluation Project of the German Society for Gynaecology and Obstetrics (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, DGGG). |
Q42599064 | Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors |
Q36089391 | Shared genetics underlying epidemiological association between endometriosis and ovarian cancer |
Q61118451 | Shared heritability and functional enrichment across six solid cancers |
Q64004349 | Shared heritability and functional enrichment across six solid cancers |
Q47137402 | Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society |
Q41514112 | Should Breast Cancer Surgery Be Done in an Outpatient Setting?: Health Economics From the Perspective of Service Providers |
Q50647639 | Simple prediction of the survival of follicles in cryopreserved human ovarian tissue. |
Q64882721 | Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes in placentas of small-for-gestational-age neonates. |
Q40816253 | Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial): a multicenter, open-label, randomized controlled trial |
Q54547212 | Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer. |
Q44470032 | Single nucleotide polymorphisms in the progesterone receptor gene and association with uterine leiomyoma tumor characteristics and disease risk |
Q30597718 | Single-source tumor documentation - reusing oncology data for different purposes |
Q46037164 | Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance. |
Q44192343 | Socioeconomic status and depression during and after pregnancy in the Franconian Maternal Health Evaluation Studies (FRAMES). |
Q44499781 | Sonographic weight estimation in fetuses with breech presentation |
Q33678242 | Spontaneous antral follicle formation and metaphase II oocyte from a non-stimulated prepubertal ovarian tissue xenotransplant |
Q64273100 | Standards Used by a Clinical and Scientific Endometriosis Center for the Diagnosis and Therapy of Patients with Endometriosis |
Q38950938 | State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer |
Q53094486 | Subjective assessment of ovarian masses using pattern recognition: the impact of experience on diagnostic performance and interobserver variability. |
Q59335365 | Supportive Infusions in Integrative Breast and Gynecological Oncology – Report on Patientsʼ Satisfaction and Self-reported Effects and Side Effects |
Q35180929 | Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGG |
Q62583463 | TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes |
Q48769304 | The 5-HTTLPR polymorphism modulates the influence on environmental stressors on peripartum depression symptoms. |
Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
Q46447105 | The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia |
Q34791139 | The German SUCCESS C Study - The First European Lifestyle Study on Breast Cancer |
Q33769034 | The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial |
Q51341861 | The Hohl instrument for optimizing total laparoscopic hysterectomy procedures. |
Q43957623 | The Hohl instrument for optimizing total laparoscopic hysterectomy: results of more than 500 procedures in a university training center |
Q37210385 | The International Endometriosis Evaluation Program (IEEP Study) - A Systematic Study for Physicians, Researchers and Patients |
Q39147158 | The PI3K Pathway: Background and Treatment Approaches |
Q36917100 | The UGT1A6_19_GG genotype is a breast cancer risk factor |
Q51833268 | The VCUAM (Vagina Cervix Uterus Adnex-associated Malformation) classification: a new classification for genital malformations. |
Q43537095 | The association of prenatal attachment and perinatal factors with pre- and postpartum depression in first-time mothers |
Q38162087 | The concept of the certification system of the German Cancer Society and its impact on gynecological cancer care |
Q36137764 | The contributions of breast density and common genetic variation to breast cancer risk |
Q43226777 | The effect of metformin treatment for 2 years without caloric restriction on endocrine and metabolic parameters in women with polycystic ovary syndrome |
Q51781776 | The era of centers: the influence of establishing specialized centers on patients' choice of hospital. |
Q51745778 | The extracorporeal perfusion of the female pig detrusor as an experimental model for the study of bladder contractility. |
Q28192341 | The extracorporeal perfusion of the swine uterus as an experimental model: The effect of tocolytic drugs |
Q43069798 | The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome |
Q43701922 | The influence of hormones on CD44 expression in endometrial and breast carcinomas. |
Q28389045 | The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial |
Q36357800 | The integrative epigenomic-transcriptomic landscape of ER positive breast cancer |
Q43186750 | The intrauterine to intra-arterial pressure ratio: a new parameter for the study of uterine contractility physiology |
Q36608476 | The perfused swine uterus model: long-term perfusion |
Q40923573 | The placental mTOR-pathway: correlation with early growth trajectories following intrauterine growth restriction? |
Q57265642 | The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant |
Q35024008 | The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing |
Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
Q21195217 | The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer |
Q61814603 | Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry |
Q37884968 | Thyroid hormone receptors and reproduction |
Q43298736 | Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome |
Q36393138 | Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy |
Q34129643 | Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center Study |
Q39376175 | Timing of sequential use of double-balloon catheter and oral misoprostol for induction of labor |
Q52887281 | Tissue remodeling and nonendometrium-like menstrual cycling are hallmarks of peritoneal endometriosis lesions. |
Q36998911 | Topotecan in cervical cancer |
Q36539580 | Touch Imprint Cytology and Stereotactically-Guided Core Needle Biopsy of Suspicious Breast Lesions: 15-Year Follow-up |
Q28547437 | Towards a Computable Data Corpus of Temporal Correlations between Drug Administration and Lab Value Changes |
Q33432594 | Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial |
Q55044220 | Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients. |
Q47663023 | Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry |
Q44267362 | Treatment of endometrial carcinoma - evidence based criteria |
Q37814633 | Treatment of heterotopic cervical pregnancies |
Q38864593 | Trophoblast expression dynamics of the tumor suppressor gene gastrokine 2. |
Q37441942 | Twenty-five-year-old Woman with Bilateral Borderline Ovarian Tumour Desiring to Preserve Fertility - Case Report and Literature Review on the Current State of Fertility Preservation in Women with Borderline Ovarian Tumours |
Q43215450 | Two naturally occurring variants of the serotonin receptor gene HTR3C are associated with nausea in pregnancy |
Q47110841 | Update Breast Cancer 2017 - Implementation of Novel Therapies |
Q52632717 | Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers. |
Q52632715 | Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention. |
Q36995438 | Update on ovarian hyperstimulation syndrome: Part 1--Incidence and pathogenesis. |
Q37102399 | Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment. |
Q39046820 | Updates on the role of receptor activator of nuclear factor κB/receptor activator of nuclear factor κB ligand/osteoprotegerin pathway in breast cancer risk and treatment |
Q34201823 | Use of Tomosynthesis in Intraoperative Digital Specimen Radiography - Is a Reduction of Breast Re-excision Rates Possible? |
Q56968394 | Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians |
Q41570633 | Using automated texture features to determine the probability for masking of a tumor on mammography, but not ultrasound |
Q60046304 | Uterine contractility changes in a perfused swine uterus model induced by local anesthetics procaine, lidocaine, and ropivacaine |
Q51586397 | Uterine contractility in response to different prostaglandins: results from extracorporeally perfused non-pregnant swine uteri. |
Q37800777 | Uterus cryopreservation in the sheep: one step closer to uterus transplantation. |
Q46258165 | Uterus cryopreservation: maintenance of uterine contractility by the use of different cryoprotocols |
Q37365192 | Utilisation of prophylactic mastectomy in 10 European centres |
Q56342454 | Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility |
Q33847791 | Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer |
Q38424468 | Xenotransplantation of cryopreserved human ovarian tissue--a systematic review of MII oocyte maturation and discussion of it as a realistic option for restoring fertility after cancer treatment |
Q51997885 | Xenotransplantation of human ovarian tissue pieces in gonadotropin-stimulated SCID mice: the effect of ovariectomy. |
Q34096155 | Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer). |
Q72990970 | [Chronic pelvic pain and chronic vulvodynia as multifactorial psychosomatic disease syndromes: results of a psychometric and clinical study taking into account musculoskeletal diseases] |
Q53050911 | [Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]. |
Q53077783 | [Future of mammography-based imaging]. |
Q53411285 | [Hereditary cancer syndromes in gynecology: what the practitioner needs to know!] |
Q73792047 | [Inflammation of the myocardium as an arrhythmia trigger] |
Q50449749 | [Pre-, peri- and postpartal depression]. |
Q70841560 | [Prenatal determination of fetal rhesus factor in amnionic cells using polymerase chain reaction] |
Q54510092 | [Reconstructive surgery of the efferent urinary tract in pelvic exenteration of gynecological tumors] |
Q67551417 | [Regulation of sterol carrier protein-2 in human luteal cells by LH and LH-RH] |
Q53311354 | [S3 guidelines on diagnostics and treatment of cervical cancer: Demands on pathology]. |
Q54384993 | [Sebaceous breast carcinoma: report of a rare histological special subtype]. |
Q58587476 | [TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes] |
Q72665378 | [The erbB gene family: significance for tumor development, prognosis and new therapeutic modalities] |
Q74602870 | [Tumor risk consultation for predisposed women from high risk cancer families] |
Q73786002 | int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reaction |
Q122925830 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study |
Q38477520 | pS2 protein detected by immunohistochemistry in archival primary breast cancer. |
Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Q56334023 | rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology |
Search more.